Applications of Benzoyl-DL-Phenylalanine in Industrial Manufacturing

Benzoyl-DL-Phenylalanine serves as a specialized intermediate in several targeted industrial applications within the pharmaceutical, peptide synthesis, and biotechnology sectors. As a manufacturer, we address not only the regulatory and technical requirements but also the detailed production integration needs of each industry.

1. Peptide Synthesis for Pharmaceutical APIs

Peptide API manufacturers use Benzoyl-DL-Phenylalanine as a protected amino acid for stepwise solid-phase peptide synthesis. Its benzoyl group provides steric hindrance, which assists during sequence elongation by preventing undesired side reactions. This intermediate is vital in assembling complex APIs, including synthetic analogues for oncological, metabolic, and cardiovascular drugs. Our clients demand strict control over optical purity, trace metal content, and residual solvents to ensure bioactive performance in regulated drug substances.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP/NF monographs for peptide intermediates
• European Pharmacopoeia (Ph. Eur.) 2.2.46 for amino acid analysis
• 21 CFR Part 211 (US cGMP for finished pharmaceuticals)

Typical usage ratio

• 5–20 mol% of total protected residues in stepwise synthesis; actual load varies per target peptide sequence and protection strategy

Downstream process integration

• Added during resin loading or coupling stages on solid-phase synthesis reactors
• Functional for N-terminal derivatization before chain elongation
• Deprotected after chain assembly prior to cleavage and purification

Final product types

• Pharmaceutical peptide APIs (e.g., hormone analogs, enzyme inhibitors)
• Generic drug intermediates
• Branded therapeutic peptides

2. Building Block in Fine Chemical Synthesis

Chemical process manufacturers incorporate Benzoyl-DL-Phenylalanine as a chiral scaffold and acylation intermediate in the production of complex fine chemicals. This material finds utility in multi-step syntheses where strict control of side chain protection and enantiomeric differentiation are essential. The selection of this intermediate supports the construction of target molecules with both aromatic and aminoacidic elements, used especially in specialty pharma and agrochemical research.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• REACH Registration for non-pharmaceutical intermediates within the EU
• Hazard Communication Standard (HCS 29 CFR 1910.1200)
• Responsible Care® guidelines for chemical process safety

Typical usage ratio

• 0.1–5% w/w in complex molecule synthesis; adjusted according to reaction yield and coupling efficiency

Downstream process integration

• Introduced as a partial acyl donor in amidation or esterification stages
• Incorporated at protected amino acid assembly points in custom syntheses
• Used for intermediate isolation before further functional group transformation

Final product types

• Custom pharmaceutical intermediates
• Specialty agrochemical building blocks
• Research-grade analytical standards

3. Research-Scale Synthesis in Biotech Laboratories

Biotech and academic research groups select Benzoyl-DL-Phenylalanine as a versatile reagent for the study of amino acid derivatives, modified peptides, and conformationally restricted scaffolds. The compound allows for structure-activity relationship analysis by providing dual chiral configurations and a benzoyl-protected aromatic residue. Order sizes and purity requirements in this segment vary, with emphasis on trace impurity profiling and batch-to-batch consistency for experimental reproducibility.

Industry compliance standards

• GLP (Good Laboratory Practice, OECD Principles)
• ISO 17025 General requirements for competence of testing/calibration laboratories
• Sigma-Aldrich laboratory reagent grade specifications (reference standard for non-production R&D use)
• Material Safety Data Sheet (MSDS) compliance

Typical usage ratio

• 0.5–10 mmol per synthesis batch; amount depends on reaction scale and target molecule quantity

Downstream process integration

• Weighted directly into round-bottom flasks or automated synthesisers during solution-phase and solid-phase protocols
• Dissolved in compatible organic solvents for coupling or protection reactions
• Purified after reaction by chromatography or crystallization as needed for research workflow

Final product types

• N- and C-terminal protected peptide derivatives
• Modified amino acid standards for analytical use
• Experimental drug candidates for in vitro assays

4. Diagnostic Reagent and Assay Development

Manufacturers of in vitro diagnostic (IVD) kits incorporate Benzoyl-DL-Phenylalanine for controlled enzyme inhibition and as a linking moiety in substrate analogs. This intermediate fits protocols to study protease activity or calibrate amino acid metabolism assays. Purity and absence of interfering substances are strictly monitored, given the sensitive enzyme detection platforms used in downstream processes. Regulatory and analytical specifications dictate both raw compound handling and finished kit integrity.

Industry compliance standards

• ISO 13485:2016 Medical devices Quality Management Systems
• IVDR (EU Regulation 2017/746 for in vitro diagnostic medical devices)
• FDA 21 CFR Part 820 Quality System Regulation
• CLSI (Clinical & Laboratory Standards Institute) guidance for performance verification

Typical usage ratio

• 0.05–0.5% w/v within formulated assay buffers or substrate mixes; optimised for assay sensitivity and linearity

Downstream process integration

• Integrated into reagent buffer systems during IVD kit formulation
• Coupled with reporter molecules or enzyme substrates at assembly
• Stabilized with other diagnostic chemicals before lyophilization and packaging

Final product types

• Enzymatic diagnostic kit panels
• Calibrators for amino acid detection systems
• Protease inhibitor controls for medical laboratory diagnostics

5. Customized Bulk Synthesis for CRO/CMO Services

Contract research and manufacturing organizations (CRO/CMO) source Benzoyl-DL-Phenylalanine to support the production of proprietary intermediates and semi-finished goods for pharmaceutical and biotech clients. The raw material acts as a controlled starting material under confidentiality, often entering the supply chain for GMP-compliant pilot or clinical lot production. Our facility ensures traceable documentation, certificate of analysis, and chain-of-custody reporting as part of every order for this sector.

Industry compliance standards

• USP General Chapter <795> and <797> for compounding standards (where applicable)
• GMP Annex 1 for manufacture of sterile medicinal products (EU)
• ISO 9001:2015 for contract manufacturing
• Client-specific technical agreements and CMO supplier qualification audits

Typical usage ratio

• 0.01–10% of final product mass depending on batch scale and stage of process (development, tech transfer, or commercial manufacturing)

Downstream process integration

• Charged into pilot plant reactors as a starting material
• Used in the protected amino acid pool for induction of chirality or protection
• Subject to specific in-process controls, sampling, and documentation according to client protocol

Final product types

• Custom-protected peptide fragments
• Clinical trial materials for pre-IND and IND submissions
• Reference intermediates for pharmaceutical synthesis validation